This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

• Narrative Content
• XML
• JSON

: BioNTech Cell & Gene Therapies GmbH

Raw json | Download

{
  "resourceType" : "Organization",
  "id" : "mii-exa-mtb-study-sponsor-biontech",
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xml:lang=\"en\" lang=\"en\"><hr/><p><b>English</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: Organization mii-exa-mtb-study-sponsor-biontech</b></p><a name=\"mii-exa-mtb-study-sponsor-biontech\"> </a><a name=\"hcmii-exa-mtb-study-sponsor-biontech\"> </a><p><b>type</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/organization-type crs}\">Clinical Research Sponsor</span></p><p><b>name</b>: BioNTech Cell &amp; Gene Therapies GmbH</p></div>"
  },
  "type" : [
    {
      "coding" : [
        {
          "system" : "http://terminology.hl7.org/CodeSystem/organization-type",
          "code" : "crs",
          "display" : "Clinical Research Sponsor"
        }
      ]
    }
  ],
  "name" : "BioNTech Cell & Gene Therapies GmbH"
}